These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12152912)

  • 61. Access to and coverage of renal replacement therapy in minorities and ethnic groups in Venezuela.
    Bellorin-Font E; Pernalete N; Meza J; Milanes CL; Carlini RG
    Kidney Int Suppl; 2005 Aug; (97):S18-22. PubMed ID: 16014094
    [TBL] [Abstract][Full Text] [Related]  

  • 62. African-Americans with End Stage Renal Disease in the Early Years of Kidney Transplantation.
    Wang JY; Lederer SE; Ross LF
    J Natl Med Assoc; 2019 Aug; 111(4):352-362. PubMed ID: 30777381
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Challenge of Providing Renal Replacement Therapy in Developing Countries: The Latin American Perspective.
    Obrador GT; Rubilar X; Agazzi E; Estefan J
    Am J Kidney Dis; 2016 Mar; 67(3):499-506. PubMed ID: 26709109
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Racial inequity in America's ESRD program.
    Reddan DN; Szczech LA; Klassen PS; Owen WF
    Semin Dial; 2000; 13(6):399-403. PubMed ID: 11130265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inequalities in access to pediatric ESRD care: a global health challenge.
    Harambat J; Ekulu PM
    Pediatr Nephrol; 2016 Mar; 31(3):353-8. PubMed ID: 26628281
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Associations of race and ethnicity with anemia management among patients initiating renal replacement therapy.
    Weisbord SD; Fried LF; Mor MK; Resnick AL; Kimmel PL; Palevsky PM; Fine MJ
    J Natl Med Assoc; 2007 Nov; 99(11):1218-26. PubMed ID: 18020096
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease.
    Harding K; Mersha TB; Webb FA; Vassalotti JA; Nicholas SB
    Am J Nephrol; 2017; 46(2):156-164. PubMed ID: 28787724
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prospective payment system and racial/ethnic disparities: a national retrospective observational study in anaemia complication among end-stage renal disease patients in the US.
    Nguyen NT; Maxwell AP; Donnelly M; O'Neill C
    BMC Nephrol; 2020 Oct; 21(1):423. PubMed ID: 33023486
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The gap between estimated incidence of end-stage renal disease and use of therapy.
    Anand S; Bitton A; Gaziano T
    PLoS One; 2013; 8(8):e72860. PubMed ID: 24023651
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Utilization of hemodiafiltration as treatment modality in renal replacement therapy for end-stage renal disease patients--a global perspective.
    Sichart JM; Moeller S
    Contrib Nephrol; 2011; 175():163-169. PubMed ID: 22188698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lessons from chronic renal diseases in African Americans: treatment implications.
    Agodoa L
    Ethn Dis; 2003; 13(2 Suppl 2):S118-24. PubMed ID: 13677426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An analysis of the adequacy of preparation for end-stage renal disease care in Michigan. Michigan Renal Plan Task Force.
    Hood SA; Schillo B; Beane GE; Rozas V; Sondheimer JH
    ASAIO J; 1995; 41(3):M422-6. PubMed ID: 8573838
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CSCI Joe Doupe Lecture: End stage renal disease among Aboriginal people.
    Hemmelgarn BR
    Clin Invest Med; 2006 Dec; 29(6):383-7. PubMed ID: 17330455
    [TBL] [Abstract][Full Text] [Related]  

  • 74. End-stage renal disease (ESRD) and vascular access grafting: a critical review.
    Szycher M
    J Biomater Appl; 1999 Apr; 13(4):297-350. PubMed ID: 10340212
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dialysis for end-stage renal disease.
    Hingorani S; Watkins SL
    Curr Opin Pediatr; 2000 Apr; 12(2):140-5. PubMed ID: 10763764
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment modalities for ESRD patients. USRDS. United State Renal Data System.
    Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S54-66. PubMed ID: 9259693
    [No Abstract]   [Full Text] [Related]  

  • 77. New insights into the epidemiology of chronic kidney disease in US Asians and Pacific Islanders.
    Hall YN; Hsu CY
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):264-9. PubMed ID: 16609293
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Renal replacement therapy in the elderly: medical, ethical, and psychosocial considerations.
    Stack AG; Messana JM
    Adv Ren Replace Ther; 2000 Jan; 7(1):52-62. PubMed ID: 10672917
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of the medical differential diagnosis to achieve optimal end-stage renal disease outcomes.
    Rodriguez RA
    Adv Ren Replace Ther; 1997 Apr; 4(2):97-111. PubMed ID: 9113226
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outpatient clinic specific for end-stage renal disease improves patient survival rate after initiating dialysis.
    Fukuzaki H; Nakata J; Nojiri S; Shimizu Y; Shirotani Y; Maeda T; Kano T; Mishiro M; Nohara N; Io H; Suzuki Y
    Sci Rep; 2023 Apr; 13(1):5991. PubMed ID: 37045851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.